RAPID DISPATCH
24/H dispatch
5 in stock
Ejal 40 optimally stimulates the hyaluronic acid receptors in the skin to reduce and quickly eliminate the signs of the natural ageing process. It is the latest generation of medium molecular weight hyaluronic acid produced to reconstruct the basic structure of the extracellular matrix (ECM) so that the cells involved in the regeneration of new fibres can re-establish their natural functional relationships. Thanks to its efficacy, it is able to restructure and strengthen the extracellular matrix, revitalising skin that is already dehydrated and damaged by ageing and sun exposure. It increases the biosynthetic capacity of fibroblasts by inducing the regeneration of an optimal physiological environment, enhancing cellular activities, hydration and the synthesis of collagen, elastin and hyaluronic acid.
USE MEDICAL STRICT. Medical device. Injection of hyaluronic acid. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
EJAL 40 is a biorevititalising agent:
- Sterilised pyrogen-free gel.
- Which replenishes the level of hyaluronic acid (HA) by counteracting its natural decrease due to the ageing process.
- MEDIXA SRL
- NAME: EJAL 40
- COMPOSITION: 40 mg sodium hyaluronate; sodium chloride; sodium phosphate monobasic dihydrate; sodium phosphate dibasic dodecahydrate; water p.p.i.
- PRESENTATION: 1 x 2 ml.
- NEEDLES: 2 x 30G × ½”.
- INDICATIONS: It is indicated in the ageing process of the skin, the effects of which include thickening of the stratum corneum (roughness and reduced skin radiance) and alteration of the elastic fibres of the dermis (wrinkles). In the repair process of dermal tissue. In cases of scarring as a result of superficial skin trauma (e.g. acne and chickenpox scars).
- INJECTION DEPTH: The most common treated areas are submural and malaric. In particular to treat these areas we suggest using Ejal 40 with a more innovative 4-point bio-revititalisation technique. The 4 BRP - 4 Bio Revitalization Points technique allows the use of a 0.25 ml injection with a 30G needle on each side of the face with only 4 points, minimising the risk of blood loss and optimising efficacy through the most homogeneous and fluid injection of hyaluronic acid.
- DURATION: - 3 treatments at one-month intervals followed by a two-month maintenance period depending on the degree of ageing.
- Repeat the cycle twice a year.
- once a month.
- USAGE: Strict medical use.
- Syringe: 1 x 2ml of EJAL 40.
- Needles: 2 x 30G × ½” needles.
- The gel is sold in a pre-filled, disposable graduated syringe.
- Each box contains one 2mL syringe of EJAL 40, 2 sterile single-use 30G × ½” needles reserved exclusively for injecting EJAL 40, instructions for use and 2 labels with the lot number.
It is ideal for décolleté, glabellal wrinkles, neck, hands, marionette lines, mentolabial folds, mouth corners, nasolabial folds, perioral folds, forehead and expression lines.
40 mg sodium hyaluronate; sodium chloride; sodium dibasic phosphate dihydrate; sodium dibasic phosphate dodecahydrate; water p.p.i.
- Ejal 40 is indicated for intradermal injection.
- In the case of sensitive skin, anaesthetic creams or patches with a local anaesthetic effect can be used before treatment. It is important to remember that anaesthesia may cause redness or slight local sensitivity.
- There are no clinical data (efficacy, tolerance) on the injection of Ejal 40 in areas already treated with another filler.
- Patients should be instructed not to use cosmetic products for 12 hours after the injection. They are also advised to avoid prolonged exposure to the sun and UV rays, as well as frequent saunas or steam baths, for one week after treatment.
- If the needle becomes obstructed, do not increase the pressure on the plunger: stop the injection and reinsert the needle.
- Do not inject into blood vessels, bones, tendons, ligaments, muscles or nerves.
- After use, dispose of the syringe and residual product.
- Do not use if the packaging is damaged.
Ejal 40 is contraindicated in the following cases:
- Patients with a tendency to hypotrophic scars.
- Patients with a history of autoimmune diseases or being treated with immunotherapy.
- Patients with known hypersensitivity to hyaluronic acid.
- Pregnant or breastfeeding women.
- Patients under the age of 18.
Treatment with Ejal 40 in patients taking anticoagulants or anti-platelet drugs should only be carried out after consultation with the doctor.
Do not use Ejal 40 in areas with inflammatory processes or skin infections (e.g. acne, herpes, etc.).
Do not use Ejal 40 in combination with laser therapy, chemical peeling or dermabrasion.
Ejal 40 is particularly indicated for the treatment of skin laxity, wrinkles, diminished tone and elasticity and before the use of intradermal fillers.
The following contraindications and precautions are based on the general guidelines for hyaluronic acid dermal fillers and are intended to provide technical information. Always consult a qualified professional before use.
The contents of the EJAL 40 syringe are sterilised with moist heat.
Ejal 40 uses medium molecular weight hyaluronic acid and a formulation designed to stimulate the regeneration of the extracellular matrix, enhancing the activity of fibroblasts and promoting the synthesis of collagen, elastin and hyaluronic acid for a more complete restructuring and revitalising effect.
In the case of sensitive skin, the doctor may apply anaesthetic creams or local patches to reduce discomfort. After the injection, it is recommended to avoid cosmetics for 12 hours, as well as sun exposure, saunas or steam baths for about a week.
The 4-point technique involves injecting about 0.25 ml per point on each side of the face, with the aim of achieving an even distribution and reducing swelling or spillage, using disposable 2 ml syringes.
After the treatment, the skin appears more hydrated, firm and radiant. Slight reddening or oedema may occur in the treated area, which generally disappears within a few hours or days.
It is not recommended to combine Ejal 40 with laser therapies, chemical peels or dermabrasion in the same areas during the same period. In the case of use with other fillers or treatments, the doctor will assess compatibility to ensure safety and efficacy.